News und Analysen
Sears Surrenders to Amazon With Kenmore Appliance Deal
As recently as 2003, Kenmore -- a private brand owned by Sears Holdings (NASDAQ: SHLD) -- held a 27% share of the U.S. appliance market. However, with customer traffic and sales in a long-term
Amazon.com Stock Slides on Lower Profitability
Profitability finally seemed to be turning a corner at Amazon.com (NASDAQ: AMZN) in 2016, following years of low margin. However, Amazon's recent second-quarter earnings report dashed bulls' hopes of
This Week in Solar
After First Solar (NASDAQ: FSLR) reported its earnings last week and SunPower (NASDAQ: SPWR) reported this week, we're starting to get a clearer picture of what the second quarter looked like for
Roundtable: 1 Stock I Refuse to Sell
The only way to make money with stocks is to buy low and sell high. That's it. There are no rules that say how long that period has to be between when you buy and when you sell. We all have those one
People Spend As Much Time on Instagram As Snapchat
Snap's (NYSE: SNAP) pitch to advertisers is it's engagement. "All advertising starts with a strong engagement, and we provide incredibly strong engagement," Chief Strategy Officer Imran Kahn said on
Should Retailers Be Running Their Own Prime Day Sales Events?
Maybe it's time retailers start jumping on Amazon.com 's (NASDAQ: AMZN) coattails and start running Prime Day sales of their own -- not just having a big sales event and hoping consumers notice, but
Tesla und Apple sind die künftigen Konkurrenten von VW, Daimler & Co!
Tesla hat die ersten Model3-Fahrzeuge ausgeliefert, und Apple-Chef Tim Cook sagte erstmals öffentlich, dass sich #Apple auf autonomes Fahren fokussiere. Keine Frage: die Fahrzeugindustrie wird sich in
3 Top Dividend Aristocrats To Own Forever
Few stocks deserve consideration as "own forever" investments. However, the Dividend Aristocrats list of companies which are S&P 500 components, and have increased their regular dividend every year
Is AbbVie About to Deliver a Blow to Gilead Sciences' Guidance?
After boosting its full-year hepatitis C revenue guidance last month, Gilead Sciences' (NASDAQ: GILD) share price has been rallying. However, the Food and Drug Administration approved AbbVie's (NYSE:
Intel Corporation Scores Another Major Design Win at Apple Inc.
Intel's (NASDAQ: INTC) cellular modem business is really starting to make some inroads at Apple (NASDAQ: AAPL).After winning a deal to supply cellular modems to Apple in support of the iPhone 7-series
Better Buy: Twitter, Inc. vs. Netflix, Inc.
Netflix (NASDAQ: NFLX) built a DVD-mailing empire, then abandoned it to fulfill a much grander digital-video-streaming vision. Twitter (NYSE: TWTR) turned SMS-powered microblogging into a social
Activision Blizzard Inc. Earnings Point to More Record Growth Ahead
Activision Blizzard (NASDAQ: ATVI) has a habit of under promising and over delivering. The video game developer this week announced second-quarter results, and -- for the sixth consecutive time -- the
Xilinx, Inc. Beat the Street Again -- so Why Isn't the Stock Soaring?
Reprogrammable microchip giant Xilinx (NASDAQ: XLNX) reported results last week, covering the first quarter of fiscal year 2018. The company beat Wall Street's earnings estimates for the reported
7 Metrics Show How Apple, Inc.'s Services Business Is on Fire
Apple's (NASDAQ: AAPL) better-than-expected third quarter took investors by surprise earlier this week. After the report, the stock hit a new all-time high. The quarter benefited from broad-based
Why MercadoLibre Inc. Stock Fell 11% Today
Shares of MercadoLibre (NASDAQ: MELI) fell as much as 11.7% on Friday, hitting that low around 2:45 p.m. EDT, after the Buenos Aires-based e-commerce company reported second-quarter earnings Thursday
3 Things Intel Corp. Earnings Told Us About Its Memory Business
Intel (NASDAQ: INTC) announced a decision to double-down on its non-volatile memory business about two years ago. The company said it would be converting its logic chip manufacturing facility in
3 New, Must-Read Quotes From Tesla, Inc.'s Elon Musk
Tesla's (NASDAQ: TSLA) second-quarter update sent shares soaring higher on Thursday. Investors seemed to like the company's better-than-expected financial results, as well as management's reassurance
Fitbit Desperately Needs Its Smartwatch to Be a Hit
Fitbit (NYSE: FIT) reported second-quarter earnings on Tuesday, and investors cheered the results, sending shares up 15%. The company isn't quite out of the woods yet, but it's making some undeniable
Will Sirius XM Offer a Free Service?
There doesn't seem to be anything wrong with Sirius XM Holdings (NASDAQ: SIRI) these days, but it doesn't mean that it's above tweaking its model. The satellite radio provider offered up some
How Intel Corporation Can Revive Desktop Chip Sales
Last quarter, Intel's (NASDAQ: INTC) Client Computing Group (CCG), which mainly relies on sales of chips into personal computers, was the star of the show. It delivered 12% year-over-year revenue
Mobile Games Drive Massive Quarter For Activision Blizzard, Inc.
A slow quarter of new releases didn't slow down Activision Blizzard, Inc. (NASDAQ: ATVI) in the second quarter. The company posted much better than expected second quarter results, driven by continued
5 Technological Innovations That Could Change the World
Image source: Getty Images.Technology is often overhyped, but sometimes there are honest-to-goodness technological innovations that have the ability to truly change the world. Consider that artificial
Illumina vs. Intuitive Surgical: Which Company Reported Better Earnings?
Illumina (NASDAQ: ILMN) and Intuitive Surgical (NASDAQ: ISRG) recently reported second-quarter earnings that were better than industry watchers' forecasts. These two game-changing healthcare companies
PayPal Has Plenty of Dancing Partners and Investors Should Be Thrilled
Investors have come to expect consistent growth from PayPal Holdings Inc (NASDAQ: PYPL) and it did not disappoint when it recently reported its third quarter results. Not only did the company surpass
Why Vertex Pharmaceuticals Skyrocketed 17.8% in July
After reporting results from mid-stage trials showing its multi-drug combination therapies improved lung function in cystic fibrosis patients, Vertex Pharmaceuticals (NASDAQ: VRTX) shares surged 17.8%